Advertisement
Organisation › Details
EIC Fund (European Innovation Council Fund)
The European Innovation Council Fund from the European Commission is an agnostic Fund: it invests across all technologies and verticals, and all EU countries and countries associated to Horizon Europe. It provides the investment component of the EIC Accelerator blended finance. The European Investment Bank acts as investment adviser to the EIC Fund. The EIC Fund aims to fill a critical financing gap and its main purpose is to support companies in the development and commercialisation of disruptive technologies, bridging with and crowding in market players, and further sharing risk by building a large network of capital providers and strategic partners suitable for co-investments and follow-on funding. The Fund pays particular attention to the empowerment and support of female founders as well as the ambition to reduce the innovation divide among EU countries. *
Start | 2020-06-01 established | |
Group | EU (govt) | |
Industry | fund | |
Industry 2 | business development (state/region) | |
Person | Hauser, Hermann (Amadeus Capital Partners 200906 Partner) | |
Person 2 | Georgieva, Svetoslava (EU (govt) 202309 Board Chair of EIC Fund) | |
Region | EU (European Union)_oo | |
Country | EU (European Union) | |
City | 1049 Brussels | |
Address record changed: 2021-07-09 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 3,600,000,000 (fund size (2021) 2021-01-06) | |
* Document for »About Section«: Sequentia Biotech S.L.. (9/27/24). "Press Release: Sequentia Biotech Secures €10 Million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications". Barcelona. | ||
Record changed: 2024-10-29 |
Advertisement
More documents for EU (govt)
- [1] European Invesmtent Bank (EIB). (1/14/25). "Press Release: Germany – EIB Provides €35 Million to Formo to Expand Production of Cheese Alternatives Free from Animal Products"....
- [2] Lumicks Technologies B.V.. (10/10/24). "Press Release: Dutch Life Science Tools [Company] Lumicks Secures €20 Million from European Investment Bank to Accelerate Drug Discovery for Cancer"....
- [3] Sequentia Biotech S.L.. (9/27/24). "Press Release: Sequentia Biotech Secures €10 Million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications". Barcelona....
- [4] Pentixapharm Holding AG. (8/26/24). "Press Release: Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency". Berlin & Würzburg....
- [5] Protembis GmbH. (7/30/24). "Press Release: German Medtech Protembis Gets €20 million EIB Backing for Technology to Protect Brain during Heart Treatment". Luxembourg & Aachen....
- [6] Boehringer Ingelheim. (7/29/24). "Press Release: CHMP Adopts Positive Opinion Recommending Approval of New and Expanded Indications for Spevigo". Ingelheim & La Jolla, CA....
- [7] Integra Therapeutics S.L.. (7/16/24). "Press Release: Integra Therapeutics to Receive up to €10.5 Million from European Commission for Its FiCAT Advanced Therapies Platform". Lausanne & San Francisco, CA....
- [8] Biovance Capital Partners. (7/9/24). "Press Release: Biovance Capital Partners Announces First Closing of Its New Biotech Fund at €51 million". Lisbon....
- [9] Nyxoah S.A.. (7/3/24). "Press Release: Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank". Mont-Saint-Guibert....
- [10] Valneva S.E.. (7/1/24). "Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top